These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Retinal rhythms in photoreceptors and dopamine synthetic rate: and the effect of a monoamineoxidase inhibitor.
    Author: Remé CE, Wirz-Justice A, Da Prada M.
    Journal: Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():405-10. PubMed ID: 6589857.
    Abstract:
    Autophagic degradation (AV) in rod inner segments undergoes a circadian rhythm that is dependent on light stimulation, being abolished in constant darkness, but persisting with dampened amplitude in constant light and reentrained after phase-shifts of the light--dark cycle. AV activity can be stimulated by light in vivo and in vitro. The monoamineoxidase type A inhibitor drug clorgyline phase delays the circadian rest-activity cycle. Clorgyline did not phase delay the rhythms of AV nor of disk-shedding, but significantly reduced AV rhythm amplitude. A rhythm of retinal dopamine (DA) level and synthetic rate persists in constant darkness, thus demonstrating the circadian nature of this rhythm. The existence of an endogenous rhythm of a putative retinal neurotransmitter may indicate some basic regulatory function of the DA system. Moreover, DA level and synthetic rate were significantly increased by clorgyline. Thus, the drug-induced reduction of retinal morphological parameters to light stimulation is paralleled by an increase of retinal DA levels. A functional relationship between the retinal DA system and photoreceptor metabolism remains to be established.
    [Abstract] [Full Text] [Related] [New Search]